XML 21 R10.htm IDEA: XBRL DOCUMENT
v3.22.2

Available-for-Sale Investments | 6 Months Ended
--- | ---
Jun. 30, 2022
Investments, Debt and Equity Securities [Abstract] |
Available-for-Sale Investments | (4) Available-for-Sale Investments The following tables summarize the available-for-sale securities held at June 30, 2022 and December 31, 2021 (in thousands):
June 30, 2022 |  | Amortized cost |  |  | Gross unrealized gains |  |  | Gross unrealized losses |  |  | Fair Value |
Commercial paper |  | $ | 56,852 |  |  | $ | — |  |  | $ | (238 | ) |  | $ | 56,614 |
Corporate debt securities |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
U.S. government agency securities and treasuries |  |  | 19,471 |  |  |  | — |  |  |  | (195 | ) |  |  | 19,276 |
Total |  | $ | 76,323 |  |  | $ | — |  |  | $ | (433 | ) |  | $ | 75,890 |
December 31, 2021 |  | Amortized cost |  |  | Gross unrealized gains |  |  | Gross unrealized losses |  |  | Fair Value |
Commercial paper |  | $ | 106,298 |  |  | $ | 8 |  |  | $ | (29 | ) |  | $ | 106,277 |
Corporate debt securities |  |  | 5,876 |  |  |  | — |  |  |  | (3 | ) |  |  | 5,873 |
U.S. government agency securities and treasuries |  |  | 8,062 |  |  |  | — |  |  |  | (21 | ) |  |  | 8,041 |
Total |  | $ | 120,236 |  |  | $ | 8 |  |  | $ | (53 | ) |  | $ | 120,191 |
The contractual maturity of all securities held at June 30, 2022 was 11 months or less. There were 27 and 20 investments in an unrealized loss position at June 30, 2022 and December 31, 2021, respectively, none of which had been in an unrealized loss position for more than twelve months. The aggregate fair value of the securities in an unrealized loss position at June 30, 2022 and December 31, 2021 was $75.9 million and $72.2 million, respectively. The Company reviews its investments for other-than-temporary impairment whenever the fair value of an investment is less than amortized cost and evidence indicates that an investment’s carrying amount is not recoverable within a reasonable period of time. To determine whether an impairment is other-than-temporary, the Company considers whether it has the ability and intent to hold the investment until a market price recovery and considers whether evidence indicating the cost of the investment is recoverable outweighs evidence to the contrary. The Company did no t hold any securities with an other-than-temporary impairment at June 30, 2022. Gross realized gains and losses on the sales of investments have not been material to the Company’s consolidated statement of operations.

X
- Definition Available for sale securities disclosure. + References No definition available. + Details
Name: | sybx_AvailableForSaleSecuritiesDisclosureTextBlock
Namespace Prefix: | sybx_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration